Pharmacy automation, long pitched primarily as a tool for cutting labour costs and medication errors, is increasingly being reframed by health-system leaders and sustainability analysts as an overlooked lever for reducing healthcare's environmental footprint — tackling drug waste, a problem that ranks among the sector's most persistent but least visible sustainability challenges, even as clinical safety failures continue to dominate industry attention.
The scale of the underlying problem is substantial: the US Food and Drug Administration receives more than 100,000 suspected medication error reports annually, with errors harming at least 7 million people a year and imposing billions of dollars in additional treatment costs and lost productivity, according to industry estimates. Beyond the direct clinical toll, poorly managed medication inventories drive significant pharmaceutical waste — expired stock, over-ordering and dispensing errors all contribute to a healthcare supply chain in which unused or incorrectly dispensed drugs are disposed of at scale, carrying environmental costs from both the original manufacturing footprint and the disposal process itself.
Automation adoption has already reached meaningful scale across major US health systems: 87.3 percent of hospitals now use some form of automated dispensing, clinical decision support or inventory analytics, according to industry survey data, while up to 73 percent use automated verification tools for prescription processing that route high-alert medications for manual pharmacist review while enabling low-risk auto-approvals. At the retail level, CVS now leverages centralised AI and robotics across more than 9,000 stores, Walgreens fills 60 percent of prescriptions for roughly 3,000 stores through centralised robotic hubs, and Walmart's automated facilities process up to 100,000 prescriptions daily.
Hospital-level deployments illustrate the throughput automation can achieve: Baptist Health, Kentucky's largest health system, opened a high-tech central pharmacy services centre with robotic infrastructure capable of filling up to 14,000 prescriptions per ten-hour shift, serving all nine of its hospitals from a single medication hub designed to reduce both errors and the inventory duplication that comes with each facility managing its own separate stock. Health system leaders argue that automation's sustainability case extends beyond waste reduction alone: by taking routine dispensing tasks off pharmacists' hands, automation frees clinical staff to focus on patient-facing care — medication therapy management, chronic disease monitoring and direct consultation — rather than functioning as what one industry commentator described as “assembly line workers.”
The environmental case is not without complications, however: newer drug categories are adding their own resource-intensive demands even as automation reduces waste elsewhere. GLP-1 medications requiring cold-chain storage, for instance, can require upwards of 4,000 ice packs a day at a single large pharmacy during summer months to maintain required temperatures — an energy-intensive requirement that health systems are increasingly weighing against automation-driven efficiency gains elsewhere in their operations as they build out sustainability strategies.
The global pharmacy automation market, valued at $6.65 billion in 2024, is projected to reach $10 billion by 2030 as adoption extends beyond large US health systems into mid-sized hospitals, community pharmacies and, increasingly, emerging markets pursuing government-backed digital health initiatives. Whether that growth translates into a genuinely meaningful sustainability dividend for healthcare overall, alongside its more established safety and cost benefits, will likely depend on how deliberately health systems choose to measure and report the waste-reduction and resource-efficiency gains automation delivers — rather than treating them as an incidental side effect of investments justified primarily on safety and labour-cost grounds.
